Related Experiment Video
Updated: Jul 26, 2025

A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
Published on: April 11, 2014
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing.
Michael J Schuh1, Kevin Mustain2, Sheena Crosby1
1Mayo Clinic, Jacksonville, Florida.
High-dose vitamin C (ascorbic acid) may increase phenytoin levels, risking toxicity. This case highlights potential adverse drug reactions, including seizures and ataxia, when combining high-dose ascorbic acid with phenytoin.
Area of Science:
- Pharmacology
- Clinical Toxicology
- Neurology
Background:
- Phenytoin is a widely used antiepileptic drug.
- Ascorbic acid (vitamin C) is a common supplement.
- Interactions between high-dose ascorbic acid and phenytoin are not well-established.
Purpose of the Study:
- To report a case of potential phenytoin toxicity due to concomitant high-dose ascorbic acid administration.
- To describe the adverse drug reactions observed in this patient.
- To inform clinicians about a possible drug interaction.
Main Methods:
- Case report detailing a patient's clinical course.
- Observation of phenytoin levels and adverse events.
- Discontinuation of interacting medications and initiation of alternative treatment.
Main Results:
- Concomitant use of high-dose ascorbic acid with phenytoin led to elevated phenytoin levels.
- The patient experienced adverse drug reactions including truncal ataxia and weakness.
- Discontinuation of ascorbic acid and phenytoin, followed by lacosamide and gabapentin, resolved symptoms.
Conclusions:
- High-dose ascorbic acid may potentiate phenytoin toxicity.
- Clinicians should exercise caution when prescribing high-dose ascorbic acid to patients on phenytoin.
- Monitoring of phenytoin levels and potential adverse effects is crucial in such cases.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Vitamins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Prevention of Further Absorption of Poison
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...